CKAP2 and ischemia: Karatas et al. (2018) reported that LB1 treatment decreased the infarct volume and the hemorrhage area in MCAO mice model. Similarly, Yigitkanli et al. (2013) found that LB1 could reduced infarct sizes and tissue plasminogen activator-associated hemorrhage in ischemia rat model.